<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03669887</url>
  </required_header>
  <id_info>
    <org_study_id>2017.268-T</org_study_id>
    <nct_id>NCT03669887</nct_id>
  </id_info>
  <brief_title>Lifestyle Modification to Improve Diet in Women With GDM</brief_title>
  <official_title>A Randomized Clinical Trial Using a Postnatal Lifestyle Modification Program to Improve Diet, Adiposity and Metabolic Outcome in Mothers With Gestational Diabetes and Their Offspring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Prince of Wales Hospital, Shatin, Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to adapt a lifestyle modification program to engage GDM women early in the&#xD;
      postnatal period to evaluate its effectiveness in reducing adiposity and metabolic parameters&#xD;
      in the mother. Women will be randomized to receive a structured intervention or standard&#xD;
      care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A complex intervention based on a proven lifestyle modification program (LMP) will be&#xD;
      delivered to participants randomized to the intervention arm, starting in the early postnatal&#xD;
      period. The intervention will consist of individualized face-to-face counseling on diet and&#xD;
      weight management, meeting with exercise instructor, followed by telephone contact.&#xD;
&#xD;
      Control will receive standard postnatal education materials and usual care provided by&#xD;
      government health service.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 12, 2018</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion achieving body weight goal</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>3% body weight change at 12 months if pre-pregnant BMI ≥ 23kg/m2, or for those with pre-pregnant BMI &lt;23 kg/m2, either back to pre-pregnant weight or maintaining within BMI &lt;23 kg/m2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in diabetes risk</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Measured by a validated risk score calculator (RUBY- Risk Understanding By Yourself)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in fasting glucose</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Measured by OGTT (changes in mmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in physical activity</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Measured by International Physical Activity Questionnaires (IPAQ) Total 7 questions on physical activity frequency according to intensity of the physical activity. Higher score indicates more physical activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in quality of life indices</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Measured by Patient Health Questionnaire (PHQ-9) total score 27. Higher score indicates greater severity of depression. (Depression Severity: 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of achieving dietary intervention goal</measure>
    <time_frame>Baseline, 8weeks, 12 months</time_frame>
    <description>Measured by a 3-day food intake record</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">317</enrollment>
  <condition>Gestational Diabetes</condition>
  <condition>Diabetes</condition>
  <condition>Childhood Obesity</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Lifestyle Modification Program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle Modification Program</intervention_name>
    <description>The intervention will consist of 5 individual face-to-face sessions at 2-weekly intervals with a dietitian with experience in lifestyle modification program, followed by monthly phone contact and smartphone text messages. All study participants in the intervention arm will also be arranged to meet with an exercise instructor at least once during the LMP on the same day as one of the dietitian appointment. Ongoing support from the exercise instructor will also be available by phone calls or emails.</description>
    <arm_group_label>Lifestyle Modification Program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Women who developed gestational diabetes in their most recent pregnancy&#xD;
&#xD;
          2. GDM is diagnosed according to the WHO 2013 criteria of FBG ≥ 5.1mmol/l, or 1 hour&#xD;
             glucose ≥10.0mmol/l, or 2 hour glucose ≥ 8.5mmol/l during 75g OGTT performed at 24-28&#xD;
             weeks of pregnancy&#xD;
&#xD;
          3. Singleton pregnancy&#xD;
&#xD;
          4. Reside normally in Hong Kong&#xD;
&#xD;
          5. Able to communicate in Chinese&#xD;
&#xD;
          6. Willing to give consent and follow study procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subjects with pre-existing diabetes (T1D or T2D)&#xD;
&#xD;
          2. Subjects with life-threatening conditions including malignancy that is not in&#xD;
             remission&#xD;
&#xD;
          3. Subjects with known psychiatric conditions including depression&#xD;
&#xD;
          4. Substance abuse or use of illicit substances&#xD;
&#xD;
          5. Subjects with significant renal impairment (eGFR&lt;60ml/min at baseline) or non-diabetic&#xD;
             renal disease (e.g. biopsy-proven glomerulonephritis or obstructive uropathy)&#xD;
&#xD;
          6. Subjects on chronic corticosteroids treatment&#xD;
&#xD;
          7. Subjects with known myocardial infarction within the preceding 3 months&#xD;
&#xD;
          8. Major physical disability&#xD;
&#xD;
          9. Participation in other intervention trials&#xD;
&#xD;
         10. Surgical or medical interventions to treat obesity&#xD;
&#xD;
         11. Pregnancy at any point during the intervention period&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women had GDM history</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald C Ma, MBBChir,FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Prince of Wales Hosptial</name>
      <address>
        <city>Shatin</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <reference>
    <citation>Tam WH, Ma RC, Yang X, Ko GT, Lao TT, Chan MH, Lam CW, Cockram CS, Chan JC. Cardiometabolic risk in Chinese women with prior gestational diabetes: a 15-year follow-up study. Gynecol Obstet Invest. 2012;73(2):168-76. doi: 10.1159/000329339. Epub 2011 Dec 16.</citation>
    <PMID>22179684</PMID>
  </reference>
  <reference>
    <citation>Tam WH, Ma RC, Yang X, Ko GT, Tong PC, Cockram CS, Sahota DS, Rogers MS, Chan JC. Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero. Pediatrics. 2008 Dec;122(6):1229-34. doi: 10.1542/peds.2008-0158.</citation>
    <PMID>19047239</PMID>
  </reference>
  <reference>
    <citation>Tam WH, Ma RCW, Ozaki R, Li AM, Chan MHM, Yuen LY, Lao TTH, Yang X, Ho CS, Tutino GE, Chan JCN. In Utero Exposure to Maternal Hyperglycemia Increases Childhood Cardiometabolic Risk in Offspring. Diabetes Care. 2017 May;40(5):679-686. doi: 10.2337/dc16-2397. Epub 2017 Mar 9.</citation>
    <PMID>28279981</PMID>
  </reference>
  <reference>
    <citation>Woo J, Sea MM, Tong P, Ko GT, Lee Z, Chan J, Chow FC. Effectiveness of a lifestyle modification programme in weight maintenance in obese subjects after cessation of treatment with Orlistat. J Eval Clin Pract. 2007 Dec;13(6):853-9.</citation>
    <PMID>18070255</PMID>
  </reference>
  <reference>
    <citation>Wong VW, Chan RS, Wong GL, Cheung BH, Chu WC, Yeung DK, Chim AM, Lai JW, Li LS, Sea MM, Chan FK, Sung JJ, Woo J, Chan HL. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol. 2013 Sep;59(3):536-42. doi: 10.1016/j.jhep.2013.04.013. Epub 2013 Apr 23.</citation>
    <PMID>23623998</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>September 12, 2018</study_first_submitted>
  <study_first_submitted_qc>September 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2018</study_first_posted>
  <last_update_submitted>December 28, 2020</last_update_submitted>
  <last_update_submitted_qc>December 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Professor Ronald C.W. Ma</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Gestational diabetes</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Lifestyle</keyword>
  <keyword>Diet Modification</keyword>
  <keyword>Childhood Obesity</keyword>
  <keyword>Diabetes Mellitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Pediatric Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>We will decide on whether to make data available based on study results and the requests received.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

